57 related articles for article (PubMed ID: 22001559)
1. DNA methylation and histone modifications modulate the β1,3 galactosyltransferase β3Gal-T5 native promoter in cancer cells.
Caretti A; Sirchia SM; Tabano S; Zulueta A; Dall'Olio F; Trinchera M
Int J Biochem Cell Biol; 2012 Jan; 44(1):84-90. PubMed ID: 22001559
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
3. Endogenous retrovirus long terminal repeats as ready-to-use mobile promoters: the case of primate beta3GAL-T5.
Dunn CA; van de Lagemaat LN; Baillie GJ; Mager DL
Gene; 2005 Dec; 364():2-12. PubMed ID: 16112824
[TBL] [Abstract][Full Text] [Related]
4. Lewis type 1 antigen synthase (beta3Gal-T5) is transcriptionally regulated by homeoproteins.
Isshiki S; Kudo T; Nishihara S; Ikehara Y; Togayachi A; Furuya A; Shitara K; Kubota T; Watanabe M; Kitajima M; Narimatsu H
J Biol Chem; 2003 Sep; 278(38):36611-20. PubMed ID: 12855703
[TBL] [Abstract][Full Text] [Related]
5. beta 1,3-Galactosyltransferase beta 3Gal-T5 acts on the GlcNAcbeta 1-->3Galbeta 1-->4GlcNAcbeta 1-->R sugar chains of carcinoembryonic antigen and other N-linked glycoproteins and is down-regulated in colon adenocarcinomas.
Salvini R; Bardoni A; Valli M; Trinchera M
J Biol Chem; 2001 Feb; 276(5):3564-73. PubMed ID: 11058588
[TBL] [Abstract][Full Text] [Related]
6. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
[TBL] [Abstract][Full Text] [Related]
7. Chromatin states of developmentally-regulated genes revealed by DNA and histone methylation patterns in zebrafish embryos.
Lindeman LC; Winata CL; Aanes H; Mathavan S; Alestrom P; Collas P
Int J Dev Biol; 2010; 54(5):803-13. PubMed ID: 20336603
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
9. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site.
Zinn RL; Pruitt K; Eguchi S; Baylin SB; Herman JG
Cancer Res; 2007 Jan; 67(1):194-201. PubMed ID: 17210699
[TBL] [Abstract][Full Text] [Related]
10. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
11. Impaired recruitment of the histone methyltransferase DOT1L contributes to the incomplete reactivation of tumor suppressor genes upon DNA demethylation.
Jacinto FV; Ballestar E; Esteller M
Oncogene; 2009 Nov; 28(47):4212-24. PubMed ID: 19734945
[TBL] [Abstract][Full Text] [Related]
12. Suppression of thymidine phosphorylase expression by promoter methylation in human cancer cells lacking enzyme activity.
Guarcello V; Blanquicett C; Naguib FN; El Kouni MH
Cancer Chemother Pharmacol; 2008 Jun; 62(1):85-96. PubMed ID: 17805539
[TBL] [Abstract][Full Text] [Related]
13. Q2ChIP, a quick and quantitative chromatin immunoprecipitation assay, unravels epigenetic dynamics of developmentally regulated genes in human carcinoma cells.
Dahl JA; Collas P
Stem Cells; 2007 Apr; 25(4):1037-46. PubMed ID: 17272500
[TBL] [Abstract][Full Text] [Related]
14. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
[TBL] [Abstract][Full Text] [Related]
15. Association between expression levels of CA 19-9 and N-acetylglucosamine-beta;1,3-galactosyltransferase 5 gene in human pancreatic cancer tissue.
Hayashi N; Nakamori S; Okami J; Nagano H; Dono K; Umeshita K; Sakon M; Narimatsu H; Monden M
Pathobiology; 2004; 71(1):26-34. PubMed ID: 14555842
[TBL] [Abstract][Full Text] [Related]
16. Beta1,3-galactosyltransferases-4/5 are novel tumor markers for gynecological cancers.
Seko A; Kataoka F; Aoki D; Sakamoto M; Nakamura T; Hatae M; Yonezawa S; Yamashita K
Tumour Biol; 2009; 30(1):43-50. PubMed ID: 19225246
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of CIITA expression in human T-cells.
van Eggermond MC; Boom DR; Klous P; Schooten E; Marquez VE; Wierda RJ; Holling TM; van den Elsen PJ
Biochem Pharmacol; 2011 Nov; 82(10):1430-7. PubMed ID: 21664896
[TBL] [Abstract][Full Text] [Related]
18. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
Osada H; Tatematsu Y; Sugito N; Horio Y; Takahashi T
Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
Stirzaker C; Song JZ; Davidson B; Clark SJ
Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of retroviral and native promoters driving expression of beta1,3-galactosyltransferase beta3Gal-T5 in human and mouse tissues.
Mare L; Trinchera M
J Biol Chem; 2007 Jan; 282(1):49-57. PubMed ID: 17107959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
